|
Monday, 08/02/2010
|
Evaluating Screening Tests for Chlamydia trachomatis in the Absence of a Gold Standard Test
Alula Hadgu, CDC; Liangliang Wang, The University of British Columbia; Nandini Dendukuri, McGill University
2:20 PM
|
Comparing Vaccination Estimates from Four Survey Designs: Vaccination Estimates from RDD, RDD+Cell, ABS, and Area Probability Sampling
Martin Barron, NORC; Karen Wooten, National Center for Immunization and Respiratory Diseases; Beth Taylor, National Center for Health Statistics
2:45 PM
|
Testing Conditional Monotonicity in the Absence of Smoothness
Miguel A. Delgado, Universidad Carlos III de Madrid; Juan Carlos Escanciano, Indiana University
2:55 PM
|
Meta-Analysis of Diagnostic Test Characteristics in the Absence of a Gold Standard Reference Test
Nandini Dendukuri, McGill University; Ian Schiller, McGill University; Lawrence Joseph, McGill University; Madhukar Pai, McGill University
3:05 PM
|
|
Tuesday, 08/03/2010
|
A Consistent Estimator of the Absolute Deviation Between Predicted and Observed Survival Functions
Matthias Schmid, University of Erlangen-Nuremberg
|
Binary Markov Random Fields with Absorbing States
Nick Larson, Iowa State University; Amy Hoeksema, Iowa State University; Karl Pazdernik, Iowa State University; Mark Kaiser, Iowa State University
|
Estimating Reduction in Absolute Breast Cancer Risk in Individuals and Populations from Modifying Risk Factors
Elisabetta Petracci, Institute of Medical Statistics and Biometry ; Adriano Decarli, Institute of Medical Statistics and Biometry ; Domenico Palli, Scientific Institute of Tuscany; Giovanna Masala, Scientific Institute of Tuscany; David Pee, Information Management Service Inc.; Ruth Pfeiffer, National Cancer Institute; Catherine Schairer, Division of Cancer Epidemiology and Genetics; Mitchell H. Gail, National Cancer Institute
8:50 AM
|
On Quality of Ancillary Data Available for Address-Based Sampling
Charles DiSogra, Knowledge Networks; J. Michael Dennis, Knowledge Networks; Mansour Fahimi, Marketing Systems Group
10:05 AM
|
Predicting the Coverage of Address-Based Sampling Frames Prior to Sample Selection
Joseph P. McMichael, RTI International; Vincent G. Iannacchione, RTI International; Bonnie Shook-Sa, RTI International; Jamie L. Ridenhour, RTI International; Katherine Morton, RTI International; James R. Chromy, RTI International
10:50 AM
|
The Implications of Geocoding Error on Address-Based Sampling
Bonnie Shook-Sa, RTI International; Joseph P. McMichael, RTI International; Jamie L. Ridenhour, RTI International
11:50 AM
|
Address-Based Sampling and the National Survey on Drug Use and Health: Evaluating the Effects of Coverage Bias
Katherine Morton, RTI International; Joseph P. McMichael, RTI International; Jamie L. Ridenhour, RTI International; Jonaki Bose, Substance Abuse and Mental Health Services Administration
12:05 PM
|
|
Thursday, 08/05/2010
|
Risk Models for Deciding Whether to Take Tamoxifen to Prevent Breast Cancer and for Allocating Public Health Resources
Mitchell H. Gail, National Cancer Institute
8:35 AM
|
Risk Stratification Markers in Clinical Practice: An FDA Perspective
Estelle Russek-Cohen, FDA
9:00 AM
|
Penalized Empirical Likelihood for High-Dimensional General Estimating Equations
Chenlei Leng, National University of Singapore; Chengyong Tang, National University of Singapore
11:15 AM
|
On the Quality of Ancillary Data Available for Address-Based Sampling
Charles DiSogra, Knowledge Networks; Erlina Hendarwan, Knowledge Networks
11:15 AM
|
'Unmatched' RDD and ABS Sample: Are We Reaching the Same Population?
Anna Fleeman, Arbitron Inc.; Robin Gentry, Arbitron Inc.; Nicole Wasikowski, Arbitron Inc.
11:55 AM
|
|